Fatigue in myotonic dystrophy type 1: a seven-year prospective study

Area of Science:

• Neurology
• Clinical Research
• Patient Outcomes

Background:

• Fatigue is a commonly reported symptom in myotonic dystrophy type 1 (DM1), with previous studies indicating prevalence rates between 50-90%.
• Understanding the longitudinal course of fatigue in DM1 is crucial for patient management and quality of life.

Purpose of the Study:

• To assess the frequency and progression of fatigue in patients with myotonic dystrophy type 1 (DM1) over a seven-year period.
• To investigate the relationship between fatigue, excessive daytime sleepiness (EDS), and muscle weakness progression in DM1.

Main Methods:

• A longitudinal study involving 64 DM1 patients at baseline and 38 after seven years.
• Utilized the Fatigue Severity Scale (FSS) and Daytime Sleepiness Scale (DSS) to quantify fatigue and sleepiness.
• Assessed muscle impairment using the Muscular Impairment Rating Scale (MIRS).

Main Results:

• At baseline, 54% of DM1 patients experienced fatigue and 46% had EDS. Fatigue was associated with older age, adult-onset DM1, and worse MIRS and DSS scores.
• After seven years, fatigue prevalence increased to 82% and EDS to 60%. The mean FSS score significantly increased from 34 to 48 (p < 0.01).
• Fatigue progression was observed, but it did not correlate with the progression of muscle weakness as measured by MIRS.

Conclusions:

• Fatigue is a highly prevalent and progressive symptom in DM1 patients.
• The progression of fatigue in DM1 is independent of the progression of muscle weakness.
• These findings highlight the need for targeted fatigue management strategies in DM1.